Skip to main content

Table 1 Prevalence of RPP target respiratory pathogens among SARS-CoV-2-positive and -negative specimens

From: Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic

RPP targets detected

SARS-CoV-2 detected

(n = 1 141)

SARS-CoV-2 not detected

(n = 51 129)

%

#

%

#

0

96.6

1102

88.7

45,359

1

3.3

38

10.6

5408

2

0.1

1

0.7

340

3

-

0

 < 0.1

17

4

-

0

 < 0.1

5

  1. RPP Respiratory Pathogen Panel, NAT nucleic acid test. Fifteen specimens are not shown: 13 where patient demographics could not be verified, one due to an error in both the SARS-CoV-2 NAT and the RPP, and one where the SARS-CoV-2 test internal control failed. Of these 15, 14 were negative for all RPP targets, and one resulted in an error for both the RPP and SARS-CoV-2 tests
Back to article page